From acquisitions and equipment purchases to stock buybacks, firms are rapidly recalibrating their business plans in the wake of the corporate-tax overhaul. Specialty drugmaker Amicus Therapeutics, for one, has decided to build a new production facility in the U.S. instead of Europe.
from WSJ.com: US Business http://ift.tt/2DAn1Cg
via IFTTT
No comments:
Post a Comment